Ainos (AIMDW) Competitors $0.13 -0.03 (-21.03%) As of 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock AIMDW vs. ATNFW, LBPSW, AEHAW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CALA, and CELUWShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences Celularity Ainos (NASDAQ:AIMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings. Which has stronger valuation and earnings, AIMDW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$106.21KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media prefer AIMDW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Ainos. 180 Life Sciences' average media sentiment score of 0.95 beat Ainos' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Ainos Neutral 180 Life Sciences Positive Is AIMDW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community prefer AIMDW or ATNFW? Ainos and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAinosN/AN/A180 Life SciencesN/AN/A Summary180 Life Sciences beats Ainos on 2 of the 3 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMDW vs. The Competition Export to ExcelMetricAinosMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.33B$5.41B$8.72BDividend YieldN/A2.44%5.38%4.23%P/E RatioN/A69.0325.7719.53Price / SalesN/A115.95399.53109.48Price / CashN/A15.9925.4426.73Price / BookN/A3.898.005.72Net IncomeN/A$132.05M$3.15B$248.44M7 Day PerformanceN/A0.02%2.36%2.33%1 Month Performance-37.48%2.98%7.18%5.79%1 Year PerformanceN/A4.35%38.58%16.82% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDWAinosN/A$0.13-21.0%N/AN/A$0.00$106.21K0.0040Gap UpATNFW180 Life SciencesN/A$0.01+7.3%N/A-19.2%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/AN/A$0.00N/A0.002ALVOWAlvotechN/A$1.64-3.5%N/A-50.1%$0.00$585.60M0.004ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02+5.2%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.09-14.6%N/AN/A$0.00$38.00M0.0070BTMDWbioteN/A$0.03flatN/A-96.4%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.07+0.9%N/A-82.9%$0.00N/A0.008CALACalithera Biosciences0.6182 of 5 stars$0.00-95.0%N/AN/A$0.00N/A0.0060Gap DownCELUWCelularityN/A$0.06flatN/A+175.2%$0.00$54.22M0.00220Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Calithera Biosciences Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMDW) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredIs Tesla a buy right now?Wall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredYour portfolio has a dangerous blind spot (fix it now)The next overnight crash could happen any day. Will you be protected or exposed? Register now to learn how som...Ninjacators | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIMDW Stock Free AIMDW Stock Alerts